Schumacher WA - Search Results

1

Arylsulfonamidopiperidone derivatives as a novel class of factor Xa inhibitors.

Shi Y, O'Connor SP, Sitkoff D, Zhang J, Shi M, Bisaha SN, Wang Y, Li C, Ruan Z, Lawrence RM, Klei HE, Kish K, Liu EC, Seiler SM, Schweizer L, Steinbacher TE, Schumacher WA, Robl JA, Macor JE, Atwal KS, Stein PD. Shi Y, et al. Among authors: schumacher wa. Bioorg Med Chem Lett. 2011 Dec 15;21(24):7516-21. doi: 10.1016/j.bmcl.2011.06.098. Epub 2011 Jun 28. Bioorg Med Chem Lett. 2011. PMID: 22041058

2

Antiplatelet activity of the long-acting thromboxane receptor antagonist BMS 180,291 in monkeys.

Schumacher WA, Steinbacher TE, Youssef S, Ogletree ML. Schumacher WA, et al. Prostaglandins. 1992 Nov;44(5):389-97. doi: 10.1016/0090-6980(92)90135-g. Prostaglandins. 1992. PMID: 1301074

3

Thrombin inhibition compared with other antithrombotic drugs in rats.

Schumacher WA, Heran CH, Steinbacher TE, Megill JR, Bird JE, Giancarli MR, Durham SK. Schumacher WA, et al. Thromb Res. 1992 Oct 15;68(2):157-66. doi: 10.1016/0049-3848(92)90031-5. Thromb Res. 1992. PMID: 1475778

4

Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.

Harris DN, Michel IM, Goldenberg HJ, Hartl KS, Allen GT, Steinbacher TE, Schumacher WA, Han WC, Hall SE, Floyd DM, et al. Harris DN, et al. Among authors: schumacher wa. J Pharmacol Exp Ther. 1992 Apr;261(1):131-7. J Pharmacol Exp Ther. 1992. PMID: 1532833

5

Thromboxane receptor activation during bronchospasm induced by platelet-activating factor.

Schumacher WA, Steinbacher TE. Schumacher WA, et al. J Lipid Mediat. 1991 Jul-Aug;4(1):97-110. J Lipid Mediat. 1991. PMID: 1832573

6

Role of thromboxane receptor activation in the bronchospastic response to endothelin.

Schumacher WA, Steinbacher TE, Allen GT, Ogletree ML. Schumacher WA, et al. Prostaglandins. 1990 Jul;40(1):71-9. doi: 10.1016/0090-6980(90)90057-3. Prostaglandins. 1990. PMID: 2143841

7

Role of thromboxane receptors in Forssman shock in guinea pigs.

Schumacher WA, Steinbacher TE, Allen GT, Ogletree ML. Schumacher WA, et al. J Appl Physiol (1985). 1989 Jul;67(1):44-51. doi: 10.1152/jappl.1989.67.1.44. J Appl Physiol (1985). 1989. PMID: 2527227

8

Superior activity of a thromboxane receptor antagonist as compared with aspirin in rat models of arterial and venous thrombosis.

Schumacher WA, Heran CL, Steinbacher TE, Youssef S, Ogletree ML. Schumacher WA, et al. J Cardiovasc Pharmacol. 1993 Oct;22(4):526-33. doi: 10.1097/00005344-199310000-00004. J Cardiovasc Pharmacol. 1993. PMID: 7505353

9

Effect of a novel thrombin active-site inhibitor on arterial and venous thrombosis.

Schumacher WA, Balasubramanian N, St Laurent DR, Seiler SM. Schumacher WA, et al. Eur J Pharmacol. 1994 Jul 1;259(2):165-71. doi: 10.1016/0014-2999(94)90506-1. Eur J Pharmacol. 1994. PMID: 7957610

10

2-[3-[2-(4,5-diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393): 2). Oral activity and efficacy in animal models of arterial thrombosis.

Seiler SM, Buchanan JO, Schumacher WA, Zavoico GB, Gamberdella M, Fleming JS, Meanwell NA. Seiler SM, et al. Among authors: schumacher wa. Thromb Res. 1994 Apr 15;74(2):125-33. doi: 10.1016/0049-3848(94)90005-1. Thromb Res. 1994. PMID: 8029813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page